Abbott Bests Biogen With $27-a-Share Bid for Facet (Update1)
by Rick Glover
Filed under Arthritis Books
Abbott Bests Biogen With $27-a-Share Bid for Facet (Update1)
Abbott Laboratories, maker of the arthritis medicine Humira, succeeded in its bid for Facet Biotech Corp. by offering 54 percent more than Biogen Idec Inc. in its rejected takeover effort.
Read more on BusinessWeek
